Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGRP Induction of Migraine Aura
NCT07021859Recruiting
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine with aura comparing CGRP with Placebo (2 arms). Primary endpoint: Incidence of migraine attacks with aura at 12 hours. Started Jun 2025; status: recruiting.
02
Drugs
calcitonin gene-related peptide
03
Conditions
migraine with aura
Beyond the preview
Go deeper on NCT07021859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07021859.